{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T03:35:21Z","timestamp":1793936121873,"version":"4.8.0"},"reference-count":44,"publisher":"American Society of Hematology","issue":"3","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,1,19]]},"abstract":"<jats:title>Key Points<\/jats:title><jats:p>MALT1 protease activity stabilizes MYC. The MALT1-MYC network might represent a therapeutic target for MCL patients.<\/jats:p>","DOI":"10.1182\/blood-2016-05-718775","type":"journal-article","created":{"date-parts":[[2016,11,19]],"date-time":"2016-11-19T03:30:34Z","timestamp":1479526234000},"page":"333-346","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":70,"title":["B-cell receptor\u2013driven MALT1 activity regulates MYC signaling in mantle cell lymphoma"],"prefix":"10.1182","volume":"129","author":[{"given":"Beiying","family":"Dai","sequence":"first","affiliation":[{"name":"Translational Oncology, Albert-Schweitzer-Campus 1, University Hospital M\u00fcnster, M\u00fcnster, Germany;"},{"name":"Cluster of Excellence EXC 1003, Cells in Motion, M\u00fcnster, Germany;"},{"name":"Fachbereich Chemie und Pharmazie, University of M\u00fcnster, M\u00fcnster, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Grau","sequence":"additional","affiliation":[{"name":"Translational Oncology, Albert-Schweitzer-Campus 1, University Hospital M\u00fcnster, M\u00fcnster, Germany;"},{"name":"Cluster of Excellence EXC 1003, Cells in Motion, M\u00fcnster, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Juilland","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, University of Lausanne, Epalinges, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Klener","sequence":"additional","affiliation":[{"name":"Institute of Pathological Physiology, First Faculty of Medicine, Charles University Prague, Prague, Czech Republic;"},{"name":"Department of Hematology, Charles University General Hospital Prague, Prague, Czech Republic;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"H\u00f6ring","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Robert Bosch Hospital, Stuttgart, Germany;"},{"name":"Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology and University of Tuebingen, Tuebingen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Molinsky","sequence":"additional","affiliation":[{"name":"Institute of Pathological Physiology, First Faculty of Medicine, Charles University Prague, Prague, Czech Republic;"},{"name":"Department of Hematology, Charles University General Hospital Prague, Prague, Czech Republic;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisela","family":"Schimmack","sequence":"additional","affiliation":[{"name":"Research Unit Cellular Signal Integration, Institute of Molecular Toxicology and Pharmacology, Helmholtz Zentrum M\u00fcnchen\u2013German Research Center for Environmental Health, Neuherberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5824-0320","authenticated-orcid":false,"given":"Sietse M.","family":"Aukema","sequence":"additional","affiliation":[{"name":"Institute of Human Genetics, Christian-Albrechts University Kiel, Kiel, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Hoster","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, Ludwig-Maximilians University Hospital Munich, Munich, Germany;"},{"name":"Institute of Medical Informatics, Biometry, and Epidemiology, Ludwig-Maximilians University of Munich, Munich, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Vogt","sequence":"additional","affiliation":[{"name":"Translational Oncology, Albert-Schweitzer-Campus 1, University Hospital M\u00fcnster, M\u00fcnster, Germany;"},{"name":"Hematopathology Section and Lymph Node Registry, Department of Pathology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette M.","family":"Staiger","sequence":"additional","affiliation":[{"name":"Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology and University of Tuebingen, Tuebingen, Germany;"},{"name":"Department of Clinical Pathology, Robert Bosch Hospital, Stuttgart, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tabea","family":"Erdmann","sequence":"additional","affiliation":[{"name":"Translational Oncology, Albert-Schweitzer-Campus 1, University Hospital M\u00fcnster, M\u00fcnster, Germany;"},{"name":"Cluster of Excellence EXC 1003, Cells in Motion, M\u00fcnster, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendan","family":"Xu","sequence":"additional","affiliation":[{"name":"Translational Oncology, Albert-Schweitzer-Campus 1, University Hospital M\u00fcnster, M\u00fcnster, Germany;"},{"name":"Cluster of Excellence EXC 1003, Cells in Motion, M\u00fcnster, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian","family":"Erdmann","sequence":"additional","affiliation":[{"name":"Translational Oncology, Albert-Schweitzer-Campus 1, University Hospital M\u00fcnster, M\u00fcnster, Germany;"},{"name":"Cluster of Excellence EXC 1003, Cells in Motion, M\u00fcnster, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Dzyuba","sequence":"additional","affiliation":[{"name":"Translational Oncology, Albert-Schweitzer-Campus 1, University Hospital M\u00fcnster, M\u00fcnster, Germany;"},{"name":"Cluster of Excellence EXC 1003, Cells in Motion, M\u00fcnster, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannelore","family":"Madle","sequence":"additional","affiliation":[{"name":"Translational Oncology, Albert-Schweitzer-Campus 1, University Hospital M\u00fcnster, M\u00fcnster, Germany;"},{"name":"Cluster of Excellence EXC 1003, Cells in Motion, M\u00fcnster, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang E.","family":"Berdel","sequence":"additional","affiliation":[{"name":"Cluster of Excellence EXC 1003, Cells in Motion, M\u00fcnster, Germany;"},{"name":"Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital M\u00fcnster, M\u00fcnster, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Trneny","sequence":"additional","affiliation":[{"name":"Department of Hematology, Charles University General Hospital Prague, Prague, Czech Republic;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Dreyling","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, Ludwig-Maximilians University Hospital Munich, Munich, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Korinna","family":"J\u00f6hrens","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, Berlin, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Lenz","sequence":"additional","affiliation":[{"name":"Department of Physics, Philipps University, Marburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Rosenwald","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of W\u00fcrzburg, W\u00fcrzburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiner","family":"Siebert","sequence":"additional","affiliation":[{"name":"Institute of Human Genetics, Christian-Albrechts University Kiel, Kiel, Germany;"},{"name":"Institute of Human Genetics, University Hospital Ulm, Ulm, Germany; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandar","family":"Tzankov","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Hospital, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram","family":"Klapper","sequence":"additional","affiliation":[{"name":"Hematopathology Section and Lymph Node Registry, Department of Pathology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Anagnostopoulos","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, Berlin, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Krappmann","sequence":"additional","affiliation":[{"name":"Research Unit Cellular Signal Integration, Institute of Molecular Toxicology and Pharmacology, Helmholtz Zentrum M\u00fcnchen\u2013German Research Center for Environmental Health, Neuherberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"German","family":"Ott","sequence":"additional","affiliation":[{"name":"Department of Clinical Pathology, Robert Bosch Hospital, Stuttgart, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margot","family":"Thome","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, University of Lausanne, Epalinges, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Lenz","sequence":"additional","affiliation":[{"name":"Translational Oncology, Albert-Schweitzer-Campus 1, University Hospital M\u00fcnster, M\u00fcnster, Germany;"},{"name":"Cluster of Excellence EXC 1003, Cells in Motion, M\u00fcnster, Germany;"},{"name":"Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital M\u00fcnster, M\u00fcnster, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"1","key":"2019111903182201100_B1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1182\/blood-2014-05-521898","article-title":"Mantle cell lymphoma: evolving management strategies","volume":"125","author":"Campo","year":"2015","journal-title":"Blood"},{"issue":"11","key":"2019111903182201100_B2","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/sj.leu.2402272","article-title":"Blastic variant of mantle cell lymphoma: a rare but highly aggressive subtype","volume":"15","author":"Bernard","year":"2001","journal-title":"Leukemia"},{"issue":"10","key":"2019111903182201100_B3","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nrc2230","article-title":"Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics","volume":"7","author":"Jares","year":"2007","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2019111903182201100_B4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1182\/blood-2010-04-189977","article-title":"Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era","volume":"117","author":"P\u00e9rez-Gal\u00e1n","year":"2011","journal-title":"Blood"},{"issue":"2","key":"2019111903182201100_B5","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1182\/blood-2007-06-095331","article-title":"A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma","volume":"111","author":"Hoster","year":"2008","journal-title":"Blood"},{"issue":"2","key":"2019111903182201100_B6","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1535-6108(03)00028-X","article-title":"The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma","volume":"3","author":"Rosenwald","year":"2003","journal-title":"Cancer Cell"},{"issue":"12","key":"2019111903182201100_B7","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1200\/JCO.2015.63.8387","article-title":"Prognostic value of Ki-67 index, cytology, and growth pattern in mantle-cell lymphoma: results from randomized trials of the European Mantle Cell Lymphoma Network","volume":"34","author":"Hoster","year":"2016","journal-title":"J Clin Oncol"},{"issue":"14","key":"2019111903182201100_B8","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1200\/JCO.2010.33.3252","article-title":"Pathogenesis of non-Hodgkin\u2019s lymphoma","volume":"29","author":"Nogai","year":"2011","journal-title":"J Clin Oncol"},{"issue":"45","key":"2019111903182201100_B9","doi-asserted-by":"crossref","first-page":"18250","DOI":"10.1073\/pnas.1314608110","article-title":"Landscape of somatic mutations and clonal evolution in mantle cell lymphoma","volume":"110","author":"Be\u00e0","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"19","key":"2019111903182201100_B10","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1182\/blood-2013-07-517177","article-title":"The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cells","volume":"123","author":"Zhang","year":"2014","journal-title":"Blood"},{"issue":"1","key":"2019111903182201100_B11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nm.3435","article-title":"Pharmacological and genomic profiling identifies NF-\u03baB-targeted treatment strategies for mantle cell lymphoma","volume":"20","author":"Rahal","year":"2014","journal-title":"Nat Med"},{"issue":"1","key":"2019111903182201100_B12","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1182\/blood-2015-11-681460","article-title":"Pathogenic role of B-cell receptor signaling and canonical NF-\u03baB activation in mantle cell lymphoma","volume":"128","author":"Saba","year":"2016","journal-title":"Blood"},{"issue":"9","key":"2019111903182201100_B13","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/ni830","article-title":"CARMA1 is a critical lipid raft-associated regulator of TCR-induced NF-kappa B activation","volume":"3","author":"Gaide","year":"2002","journal-title":"Nat Immunol"},{"issue":"16","key":"2019111903182201100_B14","doi-asserted-by":"crossref","first-page":"15870","DOI":"10.1074\/jbc.M310599200","article-title":"MALT1\/paracaspase is a signaling component downstream of CARMA1 and mediates T cell receptor-induced NF-kappaB activation","volume":"279","author":"Che","year":"2004","journal-title":"J Biol Chem"},{"issue":"3","key":"2019111903182201100_B15","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/ni1561","article-title":"T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-kappaB inhibitor A20","volume":"9","author":"Coornaert","year":"2008","journal-title":"Nat Immunol"},{"issue":"35","key":"2019111903182201100_B16","doi-asserted-by":"crossref","first-page":"14596","DOI":"10.1073\/pnas.1105020108","article-title":"Malt1-dependent RelB cleavage promotes canonical NF-kappaB activation in lymphocytes and lymphoma cell lines","volume":"108","author":"Hailfinger","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"2019111903182201100_B17","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/febs.13639","article-title":"The paracaspase MALT1 dampens NF-\u03baB signalling by cleaving the LUBAC subunit HOIL-1","volume":"283","author":"Hailfinger","year":"2016","journal-title":"FEBS J"},{"issue":"3","key":"2019111903182201100_B18","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/febs.13597","article-title":"MALT1 cleaves the E3 ubiquitin ligase HOIL-1 in activated T cells, generating a dominant negative inhibitor of LUBAC-induced NF-\u03baB signaling","volume":"283","author":"Elton","year":"2016","journal-title":"FEBS J"},{"key":"2019111903182201100_B19","doi-asserted-by":"crossref","first-page":"8777","DOI":"10.1038\/ncomms9777","article-title":"The paracaspase MALT1 cleaves HOIL1 reducing linear ubiquitination by LUBAC to dampen lymphocyte NF-\u03baB signalling","volume":"6","author":"Klein","year":"2015","journal-title":"Nat Commun"},{"issue":"9","key":"2019111903182201100_B20","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1242\/jcs.185025","article-title":"The paracaspase MALT1 cleaves the LUBAC subunit HOIL1 during antigen receptor signaling","volume":"129","author":"Douanne","year":"2016","journal-title":"J Cell Sci"},{"issue":"4","key":"2019111903182201100_B21","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.celrep.2014.10.044","article-title":"Uncoupling Malt1 threshold function from paracaspase activity results in destructive autoimmune inflammation","volume":"9","author":"Gewies","year":"2014","journal-title":"Cell Reports"},{"issue":"9","key":"2019111903182201100_B22","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/emboj.2011.85","article-title":"T-cell receptor-induced JNK activation requires proteolytic inactivation of CYLD by MALT1","volume":"30","author":"Staal","year":"2011","journal-title":"EMBO J"},{"issue":"3","key":"2019111903182201100_B23","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/ni1568","article-title":"The proteolytic activity of the paracaspase MALT1 is key in T cell activation","volume":"9","author":"Rebeaud","year":"2008","journal-title":"Nat Immunol"},{"issue":"5","key":"2019111903182201100_B24","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2013.04.034","article-title":"Malt1-induced cleavage of regnase-1 in CD4(+) helper T cells regulates immune activation","volume":"153","author":"Uehata","year":"2013","journal-title":"Cell"},{"issue":"11","key":"2019111903182201100_B25","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/ni.3008","article-title":"Cleavage of roquin and regnase-1 by the paracaspase MALT1 releases their cooperatively repressed targets to promote T(H)17 differentiation","volume":"15","author":"Jeltsch","year":"2014","journal-title":"Nat Immunol"},{"issue":"23","key":"2019111903182201100_B26","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa055351","article-title":"A biologic definition of Burkitt\u2019s lymphoma from transcriptional and genomic profiling","volume":"354","author":"Hummel","year":"2006","journal-title":"N Engl J Med"},{"issue":"2","key":"2019111903182201100_B27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2353\/jmoldx.2006.050083","article-title":"FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue","volume":"8","author":"Ventura","year":"2006","journal-title":"J Mol Diagn"},{"issue":"7089","key":"2019111903182201100_B28","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature04687","article-title":"A loss-of-function RNA interference screen for molecular targets in cancer","volume":"441","author":"Ngo","year":"2006","journal-title":"Nature"},{"issue":"6","key":"2019111903182201100_B29","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/leu.2012.367","article-title":"MCL1 is deregulated in subgroups of diffuse large B-cell lymphoma","volume":"27","author":"Wenzel","year":"2013","journal-title":"Leukemia"},{"issue":"4","key":"2019111903182201100_B30","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ni.2540","article-title":"The protease activity of the paracaspase MALT1 is controlled by monoubiquitination","volume":"14","author":"Pelzer","year":"2013","journal-title":"Nat Immunol"},{"issue":"7","key":"2019111903182201100_B31","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1038\/leu.2015.48","article-title":"Anti-CD22 and anti-CD79B antibody drug conjugates are active in different molecular diffuse large B-cell lymphoma subtypes","volume":"29","author":"Pfeifer","year":"2015","journal-title":"Leukemia"},{"issue":"30","key":"2019111903182201100_B32","doi-asserted-by":"crossref","first-page":"12420","DOI":"10.1073\/pnas.1305656110","article-title":"PTEN loss defines a PI3K\/AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphoma","volume":"110","author":"Pfeifer","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2019111903182201100_B33","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1182\/blood-2014-08-594507","article-title":"Essential role of IRF4 and MYC signaling for survival of anaplastic large cell lymphoma","volume":"125","author":"Weilemann","year":"2015","journal-title":"Blood"},{"issue":"12","key":"2019111903182201100_B34","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1158\/2159-8290.CD-14-0096","article-title":"Access to follicular dendritic cells is a pivotal step in murine chronic lymphocytic leukemia B-cell activation and proliferation","volume":"4","author":"Heinig","year":"2014","journal-title":"Cancer Discov"},{"issue":"13","key":"2019111903182201100_B35","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1182\/blood-2013-06-508028","article-title":"I\u03baB-\u03b6 controls the constitutive NF-\u03baB target gene network and survival of ABC DLBCL","volume":"122","author":"Nogai","year":"2013","journal-title":"Blood"},{"issue":"1","key":"2019111903182201100_B36","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"issue":"6","key":"2019111903182201100_B37","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJMoa1306220","article-title":"Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma","volume":"369","author":"Wang","year":"2013","journal-title":"N Engl J Med"},{"issue":"9","key":"2019111903182201100_B38","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1158\/2159-8290.CD-14-0098","article-title":"Cell-cycle reprogramming for PI3K inhibition overrides a relapse-specific C481S BTK mutation revealed by longitudinal functional genomics in mantle cell lymphoma","volume":"4","author":"Chiron","year":"2014","journal-title":"Cancer Discov"},{"issue":"23","key":"2019111903182201100_B39","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.15252\/embj.201488987","article-title":"Malt1 protease inactivation efficiently dampens immune responses but causes spontaneous autoimmunity","volume":"33","author":"Jaworski","year":"2014","journal-title":"EMBO J"},{"issue":"20","key":"2019111903182201100_B40","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1101\/gad.1712408","article-title":"Myc\u2019s broad reach","volume":"22","author":"Eilers","year":"2008","journal-title":"Genes Dev"},{"issue":"4","key":"2019111903182201100_B41","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/his.12207","article-title":"Immunohistochemical evaluation of MYC expression in mantle cell lymphoma","volume":"63","author":"Oberley","year":"2013","journal-title":"Histopathology"},{"issue":"3","key":"2019111903182201100_B42","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/his.12760","article-title":"MYC overexpression correlates with MYC amplification or translocation, and is associated with poor prognosis in mantle cell lymphoma","volume":"68","author":"Choe","year":"2016","journal-title":"Histopathology"},{"issue":"4","key":"2019111903182201100_B43","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1182\/blood-2015-07-660969","article-title":"Engagement of the B-cell receptor of chronic lymphocytic leukemia cells drives global and MYC-specific mRNA translation","volume":"127","author":"Yeomans","year":"2016","journal-title":"Blood"},{"issue":"12","key":"2019111903182201100_B44","doi-asserted-by":"crossref","first-page":"7718","DOI":"10.4049\/jimmunol.0803313","article-title":"A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains","volume":"182","author":"D\u00fcwel","year":"2009","journal-title":"J Immunol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/3\/333\/1401618\/blood718775.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/3\/333\/1401618\/blood718775.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T18:07:53Z","timestamp":1718906873000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/129\/3\/333\/36032\/Bcell-receptordriven-MALT1-activity-regulates-MYC"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,19]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,1,19]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2016-05-718775","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,19]]}}}